Current state-of-art and what is next in Immunity, Seroepidemiology and Genomics applied to GBS surveillance and vaccine development.
Senior and junior researchers from all over the world come together in parallel session 3 to discuss the present and future of immunity, seroepidemiology and genomics applied to GBS surveillance and vaccine development. The first panel will deal with host immunity at the vaginal tract with Dr. Kelly Doran, and the current state-of-art in seroepidemiology and genomics at the human and multi-host perspective with Dr. Prescilla Nagao, Prof. Ruth Zadoks and Prof. Stephen Bentley. The second panel will bring what is next in the field presented by emerging early-career leaders Dr. Meryn Bijsma, Dr. Natalia Costa and Dr. Ding Yijun.
|Conveners: Prof. Kirsty Le Doare & Dr. Tatiana Pinto|
|S1: Prof. Kelly Doran (20 min) |
Title: GBS host immunity at the vaginal tract
|S2: Dr. Prescilla Nagao, Prof. Ruth Zadoks & Prof. Stephen Bentley (Expert Panel Discussion, 25 min) |
Title: Current state-of-art in sero-epidemiology and genomics of animal and foodborne GBS and its importance to humans
|S3: Dr. Meryn Bijsma, Natalia Costa & Ding Yijun (Emerging Leaders Panel Discussion, 25 min) |
Title: What is next in GBS seroepidemiology and immunity research presented by emerging leaders in the field
|S4: Dr Hannah Davies (5 min)|
Title: Epidemiology of GBS maternal and infant disease in Kampala, Uganda
|S5: Julia Rhodes (5 min)|
Title: The US Centres for Disease Control and Prevention-led study to establish immunologic endpoints associated with protection against infant invasive group B streptococcal disease: methodology and updates
|S6: Stephanie Leung (5 min)|
Title: Stephanie Leung – Interlaboratory comparison of an antibody-mediated opsonophagocytic killing assay measuring function